These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31742915)

  • 81. Development of an FDA guidance document for clinical trials in SLE.
    Siegel JN
    Lupus; 1999; 8(8):581-5. PubMed ID: 10568893
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A proposed change in the classification of new drug clinical evaluations.
    Silson JE
    J Clin Pharmacol J New Drugs; 1968; 8(5):285-94. PubMed ID: 4877184
    [No Abstract]   [Full Text] [Related]  

  • 83. The effect of the Drug Regulation Reform Act of 1978 on clinical research, drug availability, and the public health.
    Temple RJ
    Ann N Y Acad Sci; 1981; 368():175-85. PubMed ID: 7020537
    [No Abstract]   [Full Text] [Related]  

  • 84. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 85. [The new European regulation on herbal traditional drugs. Application to the Spanish regulation].
    Carné X
    Med Clin (Barc); 2003 Nov; 121(17):655-7. PubMed ID: 14642227
    [No Abstract]   [Full Text] [Related]  

  • 86. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 87. Safe drugs and the cost of good intentions.
    Eichler HG; Abadie E; Raine JM; Salmonson T
    N Engl J Med; 2009 Apr; 360(14):1378-80. PubMed ID: 19339718
    [No Abstract]   [Full Text] [Related]  

  • 88. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 89. Strengthening of regulatory systems for medicines in the Americas.
    Etienne C; Califf R
    Rev Panam Salud Publica; 2016 May; 39(5):213-214. PubMed ID: 27706405
    [No Abstract]   [Full Text] [Related]  

  • 90. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract]   [Full Text] [Related]  

  • 91. PDA response. "Guideline for submitting documentation for sterilization process validation in applications for human and veterinary drug products". Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1995; 49(2):62-6. PubMed ID: 7780746
    [No Abstract]   [Full Text] [Related]  

  • 92. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees.
    ; ;
    Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775
    [No Abstract]   [Full Text] [Related]  

  • 93. The pharmacist's role in product selection.
    J Am Pharm Assoc; 1971 Apr; 11(4):181-99. PubMed ID: 5170866
    [No Abstract]   [Full Text] [Related]  

  • 94. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 95. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 96. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848.
    Heath WJ
    Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037
    [No Abstract]   [Full Text] [Related]  

  • 97. Statement of the APhA to the Subcommittee on Health United States Senate. 93rd Congress, 2nd session, Washington, D.C., July 22, 1974.
    Apple WS
    J Am Pharm Assoc; 1974 Oct; 14(10):572-6. PubMed ID: 4419654
    [No Abstract]   [Full Text] [Related]  

  • 98. Cancer-causing substances in food, drugs, and cosmetics.
    N Engl J Med; 1989 Apr; 320(14):934-6. PubMed ID: 2927465
    [No Abstract]   [Full Text] [Related]  

  • 99. Drug efficacy--double-blind studies.
    Basmajian JV; Adler P; Ord RL
    J Rehabil; 1974; 40(5):26-30. PubMed ID: 4606453
    [No Abstract]   [Full Text] [Related]  

  • 100. Xenotransplantation: a review of current issues.
    Greenstein JL; White-Scharf M
    J Biolaw Bus; 1998; 2(1):46-50. PubMed ID: 11657637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.